Abstract:From 1986 to 1995 a total of 97 patients > 65 years of age underwent hepatic resections at the Department of General Surgery, Hospital Lainz, Vienna, Austria. The population consisted of 39 men and 58 women with a mean age of 74.0 +/- 5.5 years. Primary neoplasia of the liver was the cause of resection in 35 patients, gallbladder cancer in 16 patients, and metastatic disease to the liver (due to colorectal cancer in 70%) in 40 patients. The rate of major resections (> or = 3 liver segments) was 96% for primary neoplasia of the liver, 70% for metastatic disease to the liver, and 50% for gallbladder cancer; the associated mortality rates were 23%, 2.5%, and 25%, respectively. The magnitude of the resection had a significant influence on survival for gallbladder cancer (p = 0.02) and for primary neoplasia of the liver (p = 0.002) but not for metastatic disease to the liver. This reflects the high rate of cirrhosis in hepatocellular and cholangiocellular carcinoma (88%) and gallbladder cancer (37.5%). Both pre- and postoperative severe liver dysfunction had a significantly higher risk for postoperative mortality and morbidity, which showed an incremental risk with age. Another organ system able to predict outcome at the beginning of treatment by its moderate severe dysfunction were the lungs. Overall, only right and extended right lobectomies carried a significantly higher risk for postoperative mortality and morbidity. Postoperative complications were recorded in 43% of our patients, with infection the most frequent problem in nearly all of these patients (95%). Pneumonia was the leading complication associated patient survival. All patients who developed pneumonia as a late complication during a complicated postoperative course died postoperatively. The postoperative Goris score of the patients who died was 6.9 +/- 2.9 (range 3-11), whereas the surviving patients' score averaged 2.2 +/- 1.9 (range 0-9), which was significantly different (p = 0.0003). None of the 54 patients with a GORIS score < or = 2 died postoperatively, whereas 5 of 6 patients with a score > or = 9 died (p = 0.0001). Severe liver dysfunction rather than the extent of resection influences clinical mortality. Patients > 80 years of age with a preoperative severe liver dysfunction showed a postoperative mortality of 57%, and all of these patients developed postoperative complications. Therefore resection cannot be recommended for those patients. Cirrhosis led to an unacceptable mortality of 44% after hepatic resection of > or = 5 liver segments for primary neoplasia of the liver. Major resections cannot be recommended in the aged with gallbladder cancer because 50% of the patients died after such operations. Overall, only resection of > or = 5 liver segments with segments I to III or less remaining were found to pose a major risk for clinical mortality and morbidity, but the cause of death was preexisting liver dysfunction and cirrhosis in all of these patients. Major resections of large neoplasia of the liver can be recommended even in the aged, but a preoperative preselection of patients with respect to liver function and pulmonary function preoperatively may help lower the postoperative morbidity and mortality, especially in patients who will undergo resection of > or = 5 liver segments. Major hepatic resection for metastatic disease to the liver in the elderly carries no additional survival risk. Patients > 65 years of age and especially those > 80 years of age are more liable to succumb to postoperative organ failure and complications, especially infections.

Major hepatectomy is safe for hepatocellular carcinoma in elderly patients with cirrhosis.

Laparoscopic Hepatectomy for Elderly Patients: Major Findings Based on a Systematic Review and Meta-Analysis.

Major Hepatectomy in Elderly Patients with Large Hepatocellular Carcinoma: A Multicenter Retrospective Observational Study.

Hepatic resection for elderly patients with hepatocellular carcinoma: a systematic review of more than 17,000 patients.

Do Elderly Patients With Stage I-II Hepatocellular Carcinoma Benefit From More Radical Surgeries? A Population-Based Analysis.

Hepatic Resection for Elderly Patients with Hepatocellular Carcinoma: a Systematic Review of More Than 17,000 Patients

Liver Resection in Hepatitis B Related-Hepatocellular Carcinoma: Clinical Outcomes and Safety in Elderly Patients

Analysis of perioperative and long-term outcome of hepatic resection for hepatocellular carcinoma in the elderly

Hepatectomy in Elderly Patients: Does Age Matter?

Liver resection for hepatocellular carcinoma in elderly patients: does age matter?

Analysis of clinicopathological features and surgical safety of hepatocellular carcinoma in aged patients

Multicenter analysis of long-term oncologic outcomes of hepatectomy for elderly patients with hepatocellular carcinoma

Overall Survival Rates Become Similar Between Percutaneous Ablation and Hepatic Resection with Increasing Age among Elderly Patients with Early Hepatocellular Carcinoma.

Safe Major Abdominal Operations: Hepatectomy, Gastrectomy and Pancreatoduodenectomy in Elder Patients

The Efficacy and Safety of Totally Laparoscopic Hepatectomy for Non-Cirrhotic Hepatocellular Carcinoma in the Elderly

Impact of Ageing on Hepatic Malignancy Resection: Is Age Really a Risk Factor for Mortality?

Perioperative Outcome of Elderly Versus Younger Patients Undergoing Major Hepatic or Pancreatic Surgery

Association between age and overall survival of patients with hepatocellular carcinoma after hepatic resection.

Hepatic resection in the elderly

The safety and risk factors of major hepatobiliary pancreatic surgery in patients older than 80 years

Clinicopathologic Features and Hepatectomy in the Elderly Patients with Primary Liver Cancer